Skip to content

Clinical trials

Completed Neoplasm Metastasis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Completed Country / region: China Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20073
20082
20092
20105
20115
20126
20132
20141
20155
20164
20173
20183
20194
20204
20218
20234
20244
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University Cancer Hospital & Institute6
Fudan University4
Novartis Pharmaceuticals3
Pfizer3
AstraZeneca2
BeiGene2
Capital Medical University2
Incyte Corporation2
Jiangsu HengRui Medicine Co., Ltd.2
Peking Union Medical College Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis70
Breast Neoplasms18
Colorectal Neoplasms7
Neoplasms6
Carcinoma, Non-Small-Cell Lung4
Stomach Neoplasms4
Carcinoma, Hepatocellular3
Lung Neoplasms3
Pancreatic Neoplasms3
Recurrence3

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.